Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Dr. Sidra Naz | Cancer Biophotonics Studies | Best Researcher Award

Research Fellow at University of Texas MD Anderson Cancer Center, United States

Dr. Sidra Naz is a dedicated physician-scientist known for her groundbreaking research in the fields of clinical medicine, public health, and epidemiology. With a strong background in medical education and research, she has contributed significantly to advancing medical knowledge through her extensive publications and collaborative projects. Dr. Naz is passionate about improving healthcare outcomes, particularly in oncology, cardiology, and neurology. Her commitment to medical research and patient care has earned her numerous accolades and recognition in the scientific community.

Profile

Google Scholar

Education 🎓

Dr. Naz completed her M.B.B.S. at Faisalabad Medical University, Pakistan, in 2017, laying the foundation for her medical expertise. She further pursued a Master of Public Health in Epidemiology at Ohio University, USA, where she honed her skills in public health research. Her continuous pursuit of knowledge has led her to collaborate with renowned institutions, enriching her understanding of complex medical conditions and their global impact.

Experience 🌟

Dr. Naz has amassed a wealth of experience through her roles at prestigious medical institutions. She currently serves as a Clinical Research Associate and Research Coordinator at the University of Texas MD Anderson Cancer Center, where she focuses on oncology research. Previously, she held a postdoctoral research fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School, contributing to neurology and hematology-oncology research. Her extensive clinical training includes externships and observerships at esteemed hospitals such as Columbia University Irving Medical Center, Duke University, and the University of Cincinnati Medical Center.

Research Interest 🔬

Dr. Naz’s research interests encompass a broad spectrum of medical fields, including oncology, cardiology, gastroenterology, and neurology. She has made significant contributions to the study of racial disparities in clinical outcomes, stroke interventions, cardiovascular diseases, and immune-related adverse events in cancer therapy. Her work in systematic reviews and meta-analyses has provided valuable insights into improving patient care and treatment strategies.

Awards & Honors 🏆

Dr. Naz’s dedication to research excellence has been recognized through numerous prestigious awards, including:

  • Paul Dudley White International Scholar Award (AHA, 2022) – Recognizing her impactful research in advancing clinical outcomes.
  • Cureus Medical Journal Laureate Award (2022) – Honoring her contributions to scientific knowledge and clinical education.
  • Expertscape Award for Excellence (2021) – Ranking her among the top 1% of global medical experts.
  • Distinguished Medical House Officer Award (2019) – Acknowledging her leadership in community health services.
  • BIDMC/Harvard Medical School Poster Presentation Award (2022) – Recognizing her innovation in medical research.

Publications 📚

Dr. Naz has authored numerous peer-reviewed journal articles and abstracts in high-impact medical journals. Some of her key publications include:

“COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review”

Year: 2021
Citations: 50

“Psychological Stress as a Risk Factor for Cardiovascular Disease: A Case-Control Study”

Year: 2020
Citations: 47

“Meningitis as an Initial Presentation of COVID-19: A Case Report”

Year: 2020
Citations: 43

“Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review”

Year: 2022
Citations: 39

“einfection of COVID-19 in Pakistan: A First Case Report”

Year: 2020
Citations: 31

“Causes of Acute Peritonitis and Its Complication”

Year: 2021
Citations: 28

“Hypovitaminosis D and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis”

Year: 2022
Citations: 27

“Association Between Hypertension and Hearing Loss”

Year: 2021
Citations: 25

“Comparison of Lipid Profile in Patients With and Without Subclinical Hypothyroidism”

Year: 2021
Citations: 25

“Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome”

Year: 2021
Citations: 19

“SGLT2 Inhibitors Among Patients With Heart Failure With Preserved Ejection Fraction: A Meta-Analysis of Randomized Controlled Trials”

Year: 2023
Citations: 18

“COVID-19-Induced Mesenteric Thrombosis”

Year: 2021
Citations: 17

Conclusion 🎉

Dr. Sidra Naz is an exceptional candidate for the Best Researcher Award, given her strong research background, high-impact publications, and international recognition. While she could further strengthen her profile by securing independent research grants and leading more first-author studies, her diverse contributions to medical science and global health make her a highly competitive nominee.

 

 

Huijuan song | Cancer Biophotonics Studies | Best Researcher Award

Prof. Huijuan song | Cancer Biophotonics Studies | Best Researcher Award

Associate researcher at Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College, China

Dr. Huijuan Song is an accomplished associate researcher at the Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College. Her groundbreaking work in biomedical engineering focuses on the development of light-responsive biomaterials for tumor immunotherapy and tissue regeneration. A pioneer in merging bioactive materials with adaptive immune regulation, Dr. Song has contributed significantly to cancer treatment innovation and regenerative medicine.

Profile

Scopus

Education📘

Dr. Song earned her academic qualifications from prestigious institutions, culminating in her current role at the Chinese Academy of Medical Sciences. Her educational journey laid the foundation for her interdisciplinary approach, integrating biomedical engineering, oncology, and regenerative biology.

Experience💼

With extensive experience leading and participating in national research projects, Dr. Song has spearheaded innovations in tumor immunotherapy and tissue repair. Her leadership in groundbreaking studies, including National Natural Science Foundation of China projects, demonstrates her expertise in interdisciplinary applications of biomedical materials.

Research Interests🔬

Dr. Song’s research revolves around immune-regulating biomaterials. Her focus includes designing bioactive materials that modulate the immune system during disease progression. By investigating adaptive immune responses and tissue immune microenvironments, she bridges the gap between fundamental research and clinical applications in oncology and regenerative medicine.

Awards🏆

Dr. Song’s achievements have been recognized through multiple awards, including grants from the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her work exemplifies excellence in biomedical engineering and tumor immunotherapy.

Publications🖊

Dr. Song has authored numerous high-impact papers in renowned journals. Each reflects her innovative contributions to biomedical engineering:

“l-2-Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia-inducible factor-1α signaling pathway”

  • Year: 2024
  • Citations: 0

“Biodegradable Plant Oil-Based Bioadhesive with Ultrastrong Wet-Tissue Adhesion for Instant Sealing Hemostasis”

  • Year: 2024
  • Citations: 0

“Photopolymerized Multifunctional Hydrogel Loaded with Asiaticoside and Growth Factor for Accelerating Diabetic Wound Healing”

  • Year: 2024
  • Citations: 0

“Glutathione Depletion-Induced Versatile Nanomedicine for Potentiating the Ferroptosis to Overcome Solid Tumor Radioresistance and Enhance Immunotherapy”

  • Year: 2024
  • Citations: 2

“Exploring the Role of Inulin in Targeting the Gut Microbiota: An Innovative Strategy for Alleviating Colonic Fibrosis Induced By Irradiation”

  • Year: 2024
  • Citations: 3

“Mesenchymal stem cell-derived extracellular vesicles targeting irradiated intestine exert therapeutic effects”

  • Year: 2024
  • Citations: 0

“NRF2 promotes radiation resistance by cooperating with TOPBP1 to activate the ATR-CHK1 signaling pathway”

  • Year: 2024
  • Citations: 4

“Association of low-dose ionising radiation with site-specific solid cancers: Chinese medical X-ray workers cohort study, 1950-1995”

  • Year: 2023
  • Citations: 1

“Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR”

  • Year: 2023
  • Citations: 3

“Macrophage metabolism reprogramming EGCG-Cu coordination capsules delivered in polyzwitterionic hydrogel for burn wound healing and regeneration”

  • Year: 2023
  • Citations: 21

These works have collectively received hundreds of citations, solidifying her position as a thought leader in biomedical research.

Conclusion🌟

Huijuan Song is an exceptional candidate for the Best Researcher Award under the World Biophotonics Research Awards program. Her innovative research, impactful publications, and translational potential make her a leading figure in the field of biomedical engineering. Strengthening her global collaborations and highlighting the biophotonics aspects of her work could further solidify her candidacy. Given her outstanding accomplishments and alignment with the award’s goals, she is highly deserving of this recognition.